Clinical Trial Update: Dyslipidemia Study Investigating The Increase In "Good Cholesterol" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an intervention to raise HDL cholesterol in dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dyslipidaemias | Phase 2 | Status: COMPLETED